Pathology/Cytology

About Essenlix

Essenlix is a private, commercial-stage diagnostics company developing the iMOST platform, a 'One-Device-For-All' system for point-of-care and self-testing. The platform leverages a unique 'intelligent fault-tolerant paradigm,' combining a single reader device with a universal Q-Card cartridge format to perform diverse assays (hematology, biochemistry, immunology, etc.) on various sample types. By utilizing nanotechnology and AI, Essenlix aims to disrupt traditional lab testing with a portable, low-cost, and easy-to-use solution that delivers rapid, accurate results. The company appears to be in an early revenue phase, commercializing its first products like the iMOST-L hematology analyzer while expanding its test menu.